Real-World Neuro Degenerative Trials

Real-World Neuro Degenerative Trials

Specialists in this complex landscape

In the past 5 years:

  • 128+Clinical Trials
  • 30+Indications
  • 2,200+Sites
  • 27,000+Patients

Enrolling patients, ensuring proper diagnosis, coordinating vendors, streamlining operations, and ensuring protocol adherence--You have a lot of considerations when it comes to administering your neuro degenerative clinical trial.

At Synteract, we understand that the central nervous system, and clinical trials involving it, are complex.

Though neuro degenerative diseases can impact patients of all ages, the numbers are set to rise as elderly populations double between now and 2050. As studies become more complex, so does the burden of study participation on patients and their caregivers. Therefore, making studies as easy to participate in as possible is our goal here at Synteract. In the last 5 years alone, we have managed more than 128 neuro degenerative trials across all phases of development.

Synteract has extensive experience in clinical development programs for drugs that address Alzheimer’s, Parkinson’s, ALS, multiple sclerosis, migraine, schizophrenia, and other neuro degenerative, pain, and psychiatric disorders. We know how to deal with lack of awareness and greater focus on acute health needs; subjective scales for clinical assessment and a limited number of validated biomarkers; and cultural barriers. We understand the challenges, from drug compliance and accountability to patient consent and retention.

At Synteract, our knowledgeable project teams, therapeutic experts, and access to top investigative sites can help you develop the best strategies to conduct your clinical studies and focus on what matters most: developing treatments to improve functioning and help the lives of patients. We can manage your entire clinical trial, provide a la carte services, or rescue failing trials with a reliable, experienced expansion of your in-house team.

Neuro Degenerative Projects Performed By Synteract

Neuro Degenerative Pie Chart

128+ projects over 5 years

  • A - Pain: 32%
  • B - Neuro Degenerative Disease: 31%
  • C - Other: 19%
  • D - Psychiatry: 18%

“We have to make participation in studies as easy as possible for the patients and their caregivers by reducing burden.”

Linda Rawlings, VP of Neurodegenerative Development at Synteract

Our highly-skilled clinical research professionals understand how important the outcomes are to both caregivers and patients. That is why we are passionate to bring clinical trials to life and help you bring new treatments to market.

Contact us to learn more about our specific neuro degenerative clinical trial services. Or just submit your RFP.

x

Submit RFI / RFP

..
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract Neuro Degenerative Clinical Trial Leadership

Linda RawlingsContact us to find out more about our Neuro Degenerative expertise and experience

Linda Rawlings, MSc, FIBMS
VP Neuro Degenerative Development

Contact us to find out more about our Neuro Degenerative expertise and experience
x

Synteract Neuro Degenerative Clinical Trial Leadership

Linda RawlingsContact us to find out more about our Neuro Degenerative expertise and experience

Linda Rawlings, MSc, FIBMS
VP Neuro Degenerative Development

Contact us to find out more about our Neuro Degenerative expertise and experience
x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required